The European Federation for Pharmaceutical Sciences (EUFEPS) has awarded its first ever Distinguished Service Award to professor Arto Urtti, Professor in the Centre for Drug Research. Dr. Urtti was awarded for providing exceptional and valuable professional service to EUFEPS, and for demonstrating initiative and dedication in these roles. For 10 years, Professor Urtti served as editor-in-chief of the European Journal of Pharmaceutical Sciences, the official journal of EUFEPS. Professor Urtti received this distinguished honor at the 5th World Conference on Drug Absorption, Transport and Delivery (WCDATD): Responding to Challenging Situations. Professor Urtti currently serves as Professor in CDR, where his interests include nanotechnology and drug delivery research, especially related difficult targets like eye and tumors. Nanotechnology and drug delivery research is an active area within CDR. Within this field; we develop innovative technologies in: ocular drug delivery and ADME, nanocarriers/biomaterials and drug delivery, complex organotypic cell models, and transdermal drug delivery.
Subscribe to this list via RSS
Blog posts tagged in Drug delivery research
The University of Helsinki has appointed CDR Research Manager Paul Bromann to serve as the Finnish representative to the European Technology Platform in Nanomedicine (ETPN in short) Mirror Group. ETPN is an initiative led by industry and set up together with the European Commission in 2005 to address the applications of nanotechnology for breakthroughs in healthcare. The ETPN supports its members in coordinating their joint research efforts and improving communication amongst the members as well as towards the European Commission and the European Member States. One of the main outcomes of this support is the elaboration and update of a Strategic Research Agenda (SRA) which serves as a reference for the EC to define their future calls. A recent outcome of the past nine months activities is the newly released White Paper, giving concrete recommendations and proposing a new set of infrastructures for nanomedicine in Europe under H2020.
The ETPN Mirror Group ensures the participation of Public Authorities at national, regional and European levels in their function as policy makers, regulators and funding bodies. The aim of the Mirror Group is to develop synergies between national programs and policies, pool resources to support the implementation of the SRA, and to promote a fertile innovation environment and a state-of-the-art research infrastructure in Europe. A key role is to facilitate the industrial academic interface from a European level down to regional levels. Mirror Group members have a broad view of the national programs and activities in the nanomedicine field, together with strong links with policy makers. They are official representatives of Member States authorities. They are in a position to establish strong links with national policy makers in order to reflect the state of the art of nanomedicine in the national programs and to disseminate strategic documents.
The list of countries represented in the ETP Nanomedicine Mirror Group is available here.
Copyright © 2012. CDR and the University of Helsinki. All Rights Reserved.
